Owen Stock1, Lavinia Gordon2, Jada Kapoor3, Susan P Walker3, Clare Whitehead3, Tu'uhevaha J Kaitu'u-Lino3, Gabrielle Pell3, Natalie J Hannan3, Stephen Tong3. 1. Department of Obstetrics and Gynaecology, Translational Obstetrics Group, University of Melbourne, Mercy Hospital for Women, Heidelberg, Victoria, Australia owen.stock@unimelb.edu.au. 2. Murdoch Children's Research Institute, The Royal Children's Hospital, Parkville, Victoria, Australia Australian Genome Research Facility Ltd, The Walter and Eliza Hall Institute, Parkville, Victoria, Australia. 3. Department of Obstetrics and Gynaecology, Translational Obstetrics Group, University of Melbourne, Mercy Hospital for Women, Heidelberg, Victoria, Australia.
Abstract
BACKGROUND: Preterm prelabor rupture of the fetal membranes (PPROM) is a significant contributor to the morbidity and mortality of preterm birth, particularly in the setting of chorioamnionitis. No sensitive or specific diagnostic or predictive test currently exists for the accurate diagnosis of chorioamnionitis. Our aim was to measure messenger RNA (mRNA) coding cytokines in the maternal blood and examine whether they were increased in association with chorioamnionitis at delivery. METHODS/ RESULTS: We performed a prospective cohort study of women recruited with PPROM at a mean gestational age of 28.9 weeks at risk of developing chorioamnionitis. Blood was sampled from participants, and the expression of mRNA coding for proinflammatory genes was measured in women with and without chorioamnionitis at the time of delivery as well as gestation-matched healthy controls. Expression was measured using quantitative polymerase chain reaction (PCR) and also digital PCR. Interleukin 1β (IL1B) mRNA expression in maternal blood was elevated in women with chorioamnionitis compared to gestation-matched controls. Importantly, among women admitted with PPROM, digital PCR confirmed a significant increase in IL1B expression in maternal blood in women with chorioamnionitis compared to women without chorioamnionitis. Polymerase chain reaction array revealed that CD14, nuclear factor of κ light polypeptide gene enhancer in B-cells 1 (NFKB1), and tumor necrosis factor receptor super family-interacting serine-threonine kinase 1 mRNA were significantly increased in women with chorioamnionitis compared to controls. Digital PCR confirmed that NFKB1 mRNA was significantly increased in patients with chorioamnionitis compared to controls and that CD14 levels increased over time in patients with PPROM having chorioamnionitis. CONCLUSION: Measuring circulating proinflammatory mRNA in women with PPROM may distinguish those with chorioamnionitis from those without, in turn providing better targeted therapies and appropriate timing of delivery.
BACKGROUND: Preterm prelabor rupture of the fetal membranes (PPROM) is a significant contributor to the morbidity and mortality of preterm birth, particularly in the setting of chorioamnionitis. No sensitive or specific diagnostic or predictive test currently exists for the accurate diagnosis of chorioamnionitis. Our aim was to measure messenger RNA (mRNA) coding cytokines in the maternal blood and examine whether they were increased in association with chorioamnionitis at delivery. METHODS/ RESULTS: We performed a prospective cohort study of women recruited with PPROM at a mean gestational age of 28.9 weeks at risk of developing chorioamnionitis. Blood was sampled from participants, and the expression of mRNA coding for proinflammatory genes was measured in women with and without chorioamnionitis at the time of delivery as well as gestation-matched healthy controls. Expression was measured using quantitative polymerase chain reaction (PCR) and also digital PCR. Interleukin 1β (IL1B) mRNA expression in maternal blood was elevated in women with chorioamnionitis compared to gestation-matched controls. Importantly, among women admitted with PPROM, digital PCR confirmed a significant increase in IL1B expression in maternal blood in women with chorioamnionitis compared to women without chorioamnionitis. Polymerase chain reaction array revealed that CD14, nuclear factor of κ light polypeptide gene enhancer in B-cells 1 (NFKB1), and tumor necrosis factor receptor super family-interacting serine-threonine kinase 1 mRNA were significantly increased in women with chorioamnionitis compared to controls. Digital PCR confirmed that NFKB1 mRNA was significantly increased in patients with chorioamnionitis compared to controls and that CD14 levels increased over time in patients with PPROM having chorioamnionitis. CONCLUSION: Measuring circulating proinflammatory mRNA in women with PPROM may distinguish those with chorioamnionitis from those without, in turn providing better targeted therapies and appropriate timing of delivery.
Authors: Jobe G Shatrov; Samuel C M Birch; Lawrence T Lam; Julie A Quinlivan; Sarah McIntyre; George L Mendz Journal: Obstet Gynecol Date: 2010-08 Impact factor: 7.661
Authors: Winnie W I Pang; Michelle H Y Tsui; Daljit Sahota; Tak Y Leung; Tze K Lau; Y M Dennis Lo; Rossa W K Chiu Journal: Prenat Diagn Date: 2009-05 Impact factor: 3.050
Authors: Rafli van de Laar; David P van der Ham; S Guid Oei; Christine Willekes; Carl P Weiner; Ben W J Mol Journal: Eur J Obstet Gynecol Reprod Biol Date: 2009-10-12 Impact factor: 2.435
Authors: William W Andrews; Suzanne P Cliver; Fred Biasini; A Myriam Peralta-Carcelen; Richard Rector; Ann I Alriksson-Schmidt; Ona Faye-Petersen; Waldemar Carlo; Robert Goldenberg; John C Hauth Journal: Am J Obstet Gynecol Date: 2008-04 Impact factor: 8.661
Authors: Andrew M Heitzer; Jamie C Piercy; Brittany N Peters; Allyssa M Mattes; Judith M Klarr; Beau Batton; Noa Ofen; Sarah Raz Journal: J Abnorm Child Psychol Date: 2020-01
Authors: Jae Young Yoo; Do Young Hyeon; Yourae Shin; Soo Min Kim; Young-Ah You; Daye Kim; Daehee Hwang; Young Ju Kim Journal: Sci Rep Date: 2021-01-27 Impact factor: 4.379